Jeong‐Gun Park

3.7k total citations
59 papers, 1.6k citations indexed

About

Jeong‐Gun Park is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Jeong‐Gun Park has authored 59 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 23 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in Jeong‐Gun Park's work include Lipoproteins and Cardiovascular Health (19 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers) and Mechanical Circulatory Support Devices (9 papers). Jeong‐Gun Park is often cited by papers focused on Lipoproteins and Cardiovascular Health (19 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers) and Mechanical Circulatory Support Devices (9 papers). Jeong‐Gun Park collaborates with scholars based in United States, Canada and United Kingdom. Jeong‐Gun Park's co-authors include Robert P. Giugliano, Michael A. Blazing, Christopher P. Cannon, Eugene Braunwald, Erin A. Bohula, Jennifer A. White, Sabina A. Murphy, Marc S. Sabatine, Terje R. Pedersen and Andrew M. Tershakovec and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Jeong‐Gun Park

57 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeong‐Gun Park United States	18	1.0k	587	425	307	244	59	1.6k
Norman E. Lepor United States	19	1.0k 1.0×	580 1.0×	426 1.0×	243 0.8×	109 0.4×	79	1.9k
Michalina Kołodziejczak Poland	17	1.2k 1.1×	782 1.3×	249 0.6×	327 1.1×	119 0.5×	30	1.6k
Norman E. Lepor United States	8	1.8k 1.7×	460 0.8×	473 1.1×	656 2.1×	86 0.4×	13	2.4k
Matthew T. Roe United States	24	1.3k 1.2×	1.0k 1.7×	251 0.6×	281 0.9×	117 0.5×	54	1.8k
J. Shawn Miles United States	6	792 0.8×	661 1.1×	226 0.5×	111 0.4×	537 2.2×	8	1.6k
Kimmo Kohtamäki Finland	7	1.2k 1.1×	511 0.9×	637 1.5×	262 0.9×	185 0.8×	9	1.9k
Ricardo Dent United States	20	1.6k 1.6×	296 0.5×	343 0.8×	684 2.2×	153 0.6×	41	2.0k
Anja Vogt Germany	19	1.1k 1.1×	397 0.7×	353 0.8×	296 1.0×	49 0.2×	66	1.5k
L. Toivanen Finland	4	1.1k 1.0×	546 0.9×	764 1.8×	262 0.9×	132 0.5×	4	1.9k
Roland Klingenberg Switzerland	27	918 0.9×	712 1.2×	198 0.5×	150 0.5×	298 1.2×	86	2.3k

Countries citing papers authored by Jeong‐Gun Park

Since Specialization

Citations

This map shows the geographic impact of Jeong‐Gun Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeong‐Gun Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeong‐Gun Park more than expected).

Fields of papers citing papers by Jeong‐Gun Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeong‐Gun Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeong‐Gun Park. The network helps show where Jeong‐Gun Park may publish in the future.

Co-authorship network of co-authors of Jeong‐Gun Park

This figure shows the co-authorship network connecting the top 25 collaborators of Jeong‐Gun Park. A scholar is included among the top collaborators of Jeong‐Gun Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeong‐Gun Park. Jeong‐Gun Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kelly, Peter J., Michelle L. O’Donoghue, Jeong‐Gun Park, et al.. (2025). Efficacy and Safety of Very Low Achieved LDL Cholesterol in Patients With Previous Ischemic Stroke. Circulation. 153(2). 86–93. 1 indexed citations

Bellavia, Andrea, Giorgio Melloni, Jeong‐Gun Park, Andrea Discacciati, & Sabina A. Murphy. (2024). Estimating and presenting hazard ratios and absolute risks from a Cox model with complex nonlinear interactions. American Journal of Epidemiology. 193(8). 1155–1160. 5 indexed citations

Daniels, Lori B., Nicholas Phreaner, David D. Berg, et al.. (2024). Sex Differences in Characteristics, Resource Utilization, and Outcomes of Cardiogenic Shock: Data From the Critical Care Cardiology Trials Network (CCCTN) Registry. Circulation Cardiovascular Quality and Outcomes. 17(8). e010614–e010614. 4 indexed citations

Bergmark, Brian A., Jeong‐Gun Park, Rose A. Hamershock, et al.. (2024). Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation. Circulation Cardiovascular Quality and Outcomes. 17(7). e010561–e010561. 1 indexed citations

Zimerman, André, Stephen D. Wiviott, Jeong‐Gun Park, et al.. (2024). Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial. European Journal of Preventive Cardiology. 31(10). 1216–1223. 8 indexed citations

Koerber, Daniel M., Jason N. Katz, Erin A. Bohula, et al.. (2024). Variation in risk-adjusted cardiac intensive care unit (CICU) length of stay and the association with in-hospital mortality: An analysis from the Critical Care Cardiology Trials Network (CCCTN) registry. American Heart Journal. 271. 28–37. 1 indexed citations

Oyama, Kazuma, Robert P. Giugliano, Christian T. Ruff, et al.. (2023). Serial Assessment of Biomarkers and Heart Failure Outcomes in Patients with Atrial Fibrillation. European Journal of Heart Failure. 25(6). 832–841. 8 indexed citations

Berg, David D., Jeong‐Gun Park, Vivian M. Baird-Zars, et al.. (2022). Patients With Acute Coronary Syndromes Admitted to Contemporary Cardiac Intensive Care Units: Insights From the CCCTN Registry. Circulation Cardiovascular Quality and Outcomes. 15(8). e008652–e008652. 7 indexed citations

Patel, Siddharth M., Jacob C. Jentzer, Carlos L. Alviar, et al.. (2022). A pragmatic lab-based tool for risk assessment in cardiac critical care: data from the Critical Care Cardiology Trials Network (CCCTN) Registry. European Heart Journal Acute Cardiovascular Care. 11(3). 252–257. 2 indexed citations

10.

Berg, David Van Den, Filipe A. Moura, Benjamin M. Scirica, et al.. (2022). ASSESSMENT OF ATHEROTHROMBOTIC RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Journal of the American College of Cardiology. 79(9). 962–962. 2 indexed citations

11.

Zelniker, Thomas A., Maddalena Ardissino, Felicita Andreotti, et al.. (2021). Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial. Circulation. 143(7). 673–684. 10 indexed citations

12.

Bonaca, Marc P., Arman Qamar, Mark A. Creager, et al.. (2019). Abstract 14348: Risk Stratification for Critical Limb Ischemia and Amputation in Patients With Atherosclerosis: Insights From the TRA2P-TIMI 50 Trial. Circulation. 1 indexed citations

13.

Charytan, David M., Marc S. Sabatine, Terje R. Pedersen, et al.. (2019). Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial. Journal of the American College of Cardiology. 73(23). 2961–2970. 121 indexed citations

14.

Qamar, Arman, Robert P. Giugliano, Erin A. Bohula, et al.. (2019). Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial. Journal of the American College of Cardiology. 74(8). 1057–1068. 26 indexed citations

15.

Zelniker, Thomas A., Petr Jarolı́m, Benjamin M. Scirica, et al.. (2019). Biomarker of Collagen Turnover (C‐Terminal Telopeptide) and Prognosis in Patients With Non‐ST‐Elevation Acute Coronary Syndromes. Journal of the American Heart Association. 8(9). e011444–e011444. 17 indexed citations

16.

Bohula, Erin A., Robert P. Giugliano, Lawrence A. Leiter, et al.. (2018). Inflammatory and Cholesterol Risk in the FOURIER Trial. Circulation. 138(2). 131–140. 193 indexed citations

17.

Bonaca, Marc P., J. Antonio Gutierrez, Christopher P. Cannon, et al.. (2018). Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial. The Lancet Diabetes & Endocrinology. 6(12). 934–943. 88 indexed citations

18.

Simon, Tracey G., Kathleen E. Corey, Christopher P. Cannon, et al.. (2018). The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe. International Journal of Cardiology. 270. 245–252. 51 indexed citations

19.

Bohula, Erin A., Stephen D. Wiviott, Robert P. Giugliano, et al.. (2017). Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation. 136(25). 2440–2450. 82 indexed citations

20.

Ruff, Christian T., Assen Goudev, João Morais, et al.. (2016). Abstract 16551: Efficacy and Safety of Oral Anticoagulation in 21105 Patients With Atrial Fibrillation Stratified by Diabetic Status in the ENGAGE AF-TIMI 48 Trial. Circulation. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact